Skip to main content

Advertisement

Table 1 Clinicopathological correlation of the expression of miR-141 in an ovarian cancer tissue array (OVC1021). The 5-fold cut-off was determined by ROC analysis

From: MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis

Parameters n(=97) miR-141 expression
≤5-fold >5-fold p
Grade
 Low (1 + 2) 50 24 (48%) 26 (52%)  
 High (3) 46 24 (52%) 22 (48%) 0.838
Stage
 Early (1) 48 31 (65%) 17 (35%)  
 Late (2 + 3) 49 18 (37%) 31 (63%) 0.008*
Metastasis
 Yes 24 5 (21%) 19 (79%)  
 No 73 44 (62%) 29 (38%) 0.001*
  1. *P < 0.05